Compile Data Set for Download or QSAR
Report error Found 152 Enz. Inhib. hit(s) with all data for entry = 8708
TargetHistone deacetylase 1(Human)
Rodin Therapeutics

US Patent
LigandPNGBDBM413936(US10421756, Compound 120)
Affinity DataKd: <100nMAssay Description:HDAC2 containing a C-terminal HIS-Tag (Proteros) and fluorescently-labeled anti-HIS-antibody are diluted in one vial in assay buffer 50 mM Tris, pH 8...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/12/2020
Entry Details
US Patent

TargetHistone deacetylase 1(Human)
Rodin Therapeutics

US Patent
LigandPNGBDBM413968(US10421756, Compound 152)
Affinity DataKd: <100nMAssay Description:HDAC2 containing a C-terminal HIS-Tag (Proteros) and fluorescently-labeled anti-HIS-antibody are diluted in one vial in assay buffer 50 mM Tris, pH 8...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/12/2020
Entry Details
US Patent

TargetHistone deacetylase 1(Human)
Rodin Therapeutics

US Patent
LigandPNGBDBM413934(US10421756, Compound 118)
Affinity DataKd: <100nMAssay Description:HDAC2 containing a C-terminal HIS-Tag (Proteros) and fluorescently-labeled anti-HIS-antibody are diluted in one vial in assay buffer 50 mM Tris, pH 8...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/12/2020
Entry Details
US Patent

TargetHistone deacetylase 2(Human)
Rodin Therapeutics

US Patent
LigandPNGBDBM413967(US10421756, Compound 151)
Affinity DataKd: <100nMAssay Description:HDAC2 containing a C-terminal HIS-Tag (Proteros) and fluorescently-labeled anti-HIS-antibody are diluted in one vial in assay buffer 50 mM Tris, pH 8...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/12/2020
Entry Details
US Patent

TargetHistone deacetylase 1(Human)
Rodin Therapeutics

US Patent
LigandPNGBDBM413967(US10421756, Compound 151)
Affinity DataKd: <100nMAssay Description:HDAC2 containing a C-terminal HIS-Tag (Proteros) and fluorescently-labeled anti-HIS-antibody are diluted in one vial in assay buffer 50 mM Tris, pH 8...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/12/2020
Entry Details
US Patent

TargetHistone deacetylase 2(Human)
Rodin Therapeutics

US Patent
LigandPNGBDBM413968(US10421756, Compound 152)
Affinity DataKd: <100nMAssay Description:HDAC2 containing a C-terminal HIS-Tag (Proteros) and fluorescently-labeled anti-HIS-antibody are diluted in one vial in assay buffer 50 mM Tris, pH 8...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/12/2020
Entry Details
US Patent

TargetHistone deacetylase 1(Human)
Rodin Therapeutics

US Patent
LigandPNGBDBM413963(US10421756, Compound 147)
Affinity DataKd: <100nMAssay Description:HDAC2 containing a C-terminal HIS-Tag (Proteros) and fluorescently-labeled anti-HIS-antibody are diluted in one vial in assay buffer 50 mM Tris, pH 8...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/12/2020
Entry Details
US Patent

TargetHistone deacetylase 1(Human)
Rodin Therapeutics

US Patent
LigandPNGBDBM413944(US10421756, Compound 128)
Affinity DataKd: <100nMAssay Description:HDAC2 containing a C-terminal HIS-Tag (Proteros) and fluorescently-labeled anti-HIS-antibody are diluted in one vial in assay buffer 50 mM Tris, pH 8...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/12/2020
Entry Details
US Patent

TargetHistone deacetylase 1(Human)
Rodin Therapeutics

US Patent
LigandPNGBDBM413945(US10421756, Compound 129)
Affinity DataKd: <100nMAssay Description:HDAC2 containing a C-terminal HIS-Tag (Proteros) and fluorescently-labeled anti-HIS-antibody are diluted in one vial in assay buffer 50 mM Tris, pH 8...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/12/2020
Entry Details
US Patent

TargetHistone deacetylase 1(Human)
Rodin Therapeutics

US Patent
LigandPNGBDBM413977(US10421756, Compound 161)
Affinity DataKd: <100nMAssay Description:HDAC2 containing a C-terminal HIS-Tag (Proteros) and fluorescently-labeled anti-HIS-antibody are diluted in one vial in assay buffer 50 mM Tris, pH 8...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/12/2020
Entry Details
US Patent

TargetHistone deacetylase 2(Human)
Rodin Therapeutics

US Patent
LigandPNGBDBM413978(US10421756, Compound 162)
Affinity DataKd: <100nMAssay Description:HDAC2 containing a C-terminal HIS-Tag (Proteros) and fluorescently-labeled anti-HIS-antibody are diluted in one vial in assay buffer 50 mM Tris, pH 8...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/12/2020
Entry Details
US Patent

TargetHistone deacetylase 1(Human)
Rodin Therapeutics

US Patent
LigandPNGBDBM413942(US10421756, Compound 126)
Affinity DataKd: <100nMAssay Description:HDAC2 containing a C-terminal HIS-Tag (Proteros) and fluorescently-labeled anti-HIS-antibody are diluted in one vial in assay buffer 50 mM Tris, pH 8...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/12/2020
Entry Details
US Patent

TargetHistone deacetylase 1(Human)
Rodin Therapeutics

US Patent
LigandPNGBDBM413974(US10421756, Compound 158)
Affinity DataKd: <100nMAssay Description:HDAC2 containing a C-terminal HIS-Tag (Proteros) and fluorescently-labeled anti-HIS-antibody are diluted in one vial in assay buffer 50 mM Tris, pH 8...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/12/2020
Entry Details
US Patent

TargetHistone deacetylase 1(Human)
Rodin Therapeutics

US Patent
LigandPNGBDBM413943(US10421756, Compound 127)
Affinity DataKd: <100nMAssay Description:HDAC2 containing a C-terminal HIS-Tag (Proteros) and fluorescently-labeled anti-HIS-antibody are diluted in one vial in assay buffer 50 mM Tris, pH 8...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/12/2020
Entry Details
US Patent

TargetHistone deacetylase 1(Human)
Rodin Therapeutics

US Patent
LigandPNGBDBM413975(US10421756, Compound 159)
Affinity DataKd: <100nMAssay Description:HDAC2 containing a C-terminal HIS-Tag (Proteros) and fluorescently-labeled anti-HIS-antibody are diluted in one vial in assay buffer 50 mM Tris, pH 8...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/12/2020
Entry Details
US Patent

TargetHistone deacetylase 1(Human)
Rodin Therapeutics

US Patent
LigandPNGBDBM413972(US10421756, Compound 156)
Affinity DataKd: <100nMAssay Description:HDAC2 containing a C-terminal HIS-Tag (Proteros) and fluorescently-labeled anti-HIS-antibody are diluted in one vial in assay buffer 50 mM Tris, pH 8...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/12/2020
Entry Details
US Patent

TargetHistone deacetylase 1(Human)
Rodin Therapeutics

US Patent
LigandPNGBDBM413941(US10421756, Compound 125)
Affinity DataKd: <100nMAssay Description:HDAC2 containing a C-terminal HIS-Tag (Proteros) and fluorescently-labeled anti-HIS-antibody are diluted in one vial in assay buffer 50 mM Tris, pH 8...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/12/2020
Entry Details
US Patent

TargetHistone deacetylase 1(Human)
Rodin Therapeutics

US Patent
LigandPNGBDBM413973(US10421756, Compound 157)
Affinity DataKd: <100nMAssay Description:HDAC2 containing a C-terminal HIS-Tag (Proteros) and fluorescently-labeled anti-HIS-antibody are diluted in one vial in assay buffer 50 mM Tris, pH 8...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/12/2020
Entry Details
US Patent

TargetHistone deacetylase 1(Human)
Rodin Therapeutics

US Patent
LigandPNGBDBM413938(US10421756, Compound 122)
Affinity DataKd: <100nMAssay Description:HDAC2 containing a C-terminal HIS-Tag (Proteros) and fluorescently-labeled anti-HIS-antibody are diluted in one vial in assay buffer 50 mM Tris, pH 8...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/12/2020
Entry Details
US Patent

TargetHistone deacetylase 1(Human)
Rodin Therapeutics

US Patent
LigandPNGBDBM413952(US10421756, Compound 136)
Affinity DataKd: <100nMAssay Description:HDAC2 containing a C-terminal HIS-Tag (Proteros) and fluorescently-labeled anti-HIS-antibody are diluted in one vial in assay buffer 50 mM Tris, pH 8...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/12/2020
Entry Details
US Patent

TargetHistone deacetylase 1(Human)
Rodin Therapeutics

US Patent
LigandPNGBDBM413984(US10421756, Compound 168)
Affinity DataKd: <100nMAssay Description:HDAC2 containing a C-terminal HIS-Tag (Proteros) and fluorescently-labeled anti-HIS-antibody are diluted in one vial in assay buffer 50 mM Tris, pH 8...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/12/2020
Entry Details
US Patent

TargetHistone deacetylase 1(Human)
Rodin Therapeutics

US Patent
LigandPNGBDBM413918(US10421756, Compound 102)
Affinity DataKd: <100nMAssay Description:HDAC2 containing a C-terminal HIS-Tag (Proteros) and fluorescently-labeled anti-HIS-antibody are diluted in one vial in assay buffer 50 mM Tris, pH 8...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/12/2020
Entry Details
US Patent

TargetHistone deacetylase 2(Human)
Rodin Therapeutics

US Patent
LigandPNGBDBM413984(US10421756, Compound 168)
Affinity DataKd: <100nMAssay Description:HDAC2 containing a C-terminal HIS-Tag (Proteros) and fluorescently-labeled anti-HIS-antibody are diluted in one vial in assay buffer 50 mM Tris, pH 8...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/12/2020
Entry Details
US Patent

TargetHistone deacetylase 1(Human)
Rodin Therapeutics

US Patent
LigandPNGBDBM413949(US10421756, Compound 133)
Affinity DataKd: <100nMAssay Description:HDAC2 containing a C-terminal HIS-Tag (Proteros) and fluorescently-labeled anti-HIS-antibody are diluted in one vial in assay buffer 50 mM Tris, pH 8...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/12/2020
Entry Details
US Patent

TargetHistone deacetylase 1(Human)
Rodin Therapeutics

US Patent
LigandPNGBDBM413917(US10421756, Compound 101)
Affinity DataKd: <100nMAssay Description:HDAC2 containing a C-terminal HIS-Tag (Proteros) and fluorescently-labeled anti-HIS-antibody are diluted in one vial in assay buffer 50 mM Tris, pH 8...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/12/2020
Entry Details
US Patent

TargetHistone deacetylase 1(Human)
Rodin Therapeutics

US Patent
LigandPNGBDBM413946(US10421756, Compound 130)
Affinity DataKd: <100nMAssay Description:HDAC2 containing a C-terminal HIS-Tag (Proteros) and fluorescently-labeled anti-HIS-antibody are diluted in one vial in assay buffer 50 mM Tris, pH 8...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/12/2020
Entry Details
US Patent

TargetHistone deacetylase 1(Human)
Rodin Therapeutics

US Patent
LigandPNGBDBM413978(US10421756, Compound 162)
Affinity DataKd: <100nMAssay Description:HDAC2 containing a C-terminal HIS-Tag (Proteros) and fluorescently-labeled anti-HIS-antibody are diluted in one vial in assay buffer 50 mM Tris, pH 8...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/12/2020
Entry Details
US Patent

TargetHistone deacetylase 2(Human)
Rodin Therapeutics

US Patent
LigandPNGBDBM413916(US10421756, Compound 100)
Affinity DataKd: <100nMAssay Description:HDAC2 containing a C-terminal HIS-Tag (Proteros) and fluorescently-labeled anti-HIS-antibody are diluted in one vial in assay buffer 50 mM Tris, pH 8...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/12/2020
Entry Details
US Patent

TargetHistone deacetylase 1(Human)
Rodin Therapeutics

US Patent
LigandPNGBDBM413990(US10421756, Compound 174)
Affinity DataKd: <100nMAssay Description:HDAC2 containing a C-terminal HIS-Tag (Proteros) and fluorescently-labeled anti-HIS-antibody are diluted in one vial in assay buffer 50 mM Tris, pH 8...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/12/2020
Entry Details
US Patent

TargetHistone deacetylase 2(Human)
Rodin Therapeutics

US Patent
LigandPNGBDBM413991(US10421756, Compound 175)
Affinity DataKd: <100nMAssay Description:HDAC2 containing a C-terminal HIS-Tag (Proteros) and fluorescently-labeled anti-HIS-antibody are diluted in one vial in assay buffer 50 mM Tris, pH 8...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/12/2020
Entry Details
US Patent

TargetHistone deacetylase 1(Human)
Rodin Therapeutics

US Patent
LigandPNGBDBM413959(US10421756, Compound 143)
Affinity DataKd: <100nMAssay Description:HDAC2 containing a C-terminal HIS-Tag (Proteros) and fluorescently-labeled anti-HIS-antibody are diluted in one vial in assay buffer 50 mM Tris, pH 8...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/12/2020
Entry Details
US Patent

TargetHistone deacetylase 1(Human)
Rodin Therapeutics

US Patent
LigandPNGBDBM413991(US10421756, Compound 175)
Affinity DataKd: <100nMAssay Description:HDAC2 containing a C-terminal HIS-Tag (Proteros) and fluorescently-labeled anti-HIS-antibody are diluted in one vial in assay buffer 50 mM Tris, pH 8...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/12/2020
Entry Details
US Patent

TargetHistone deacetylase 1(Human)
Rodin Therapeutics

US Patent
LigandPNGBDBM413989(US10421756, Compound 173)
Affinity DataKd: <100nMAssay Description:HDAC2 containing a C-terminal HIS-Tag (Proteros) and fluorescently-labeled anti-HIS-antibody are diluted in one vial in assay buffer 50 mM Tris, pH 8...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/12/2020
Entry Details
US Patent

TargetHistone deacetylase 2(Human)
Rodin Therapeutics

US Patent
LigandPNGBDBM413990(US10421756, Compound 174)
Affinity DataKd: <100nMAssay Description:HDAC2 containing a C-terminal HIS-Tag (Proteros) and fluorescently-labeled anti-HIS-antibody are diluted in one vial in assay buffer 50 mM Tris, pH 8...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/12/2020
Entry Details
US Patent

TargetHistone deacetylase 2(Human)
Rodin Therapeutics

US Patent
LigandPNGBDBM413955(US10421756, Compound 139)
Affinity DataKd: <100nMAssay Description:HDAC2 containing a C-terminal HIS-Tag (Proteros) and fluorescently-labeled anti-HIS-antibody are diluted in one vial in assay buffer 50 mM Tris, pH 8...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/12/2020
Entry Details
US Patent

TargetHistone deacetylase 1(Human)
Rodin Therapeutics

US Patent
LigandPNGBDBM413955(US10421756, Compound 139)
Affinity DataKd: <100nMAssay Description:HDAC2 containing a C-terminal HIS-Tag (Proteros) and fluorescently-labeled anti-HIS-antibody are diluted in one vial in assay buffer 50 mM Tris, pH 8...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/12/2020
Entry Details
US Patent

TargetHistone deacetylase 1(Human)
Rodin Therapeutics

US Patent
LigandPNGBDBM413937(US10421756, Compound 121)
Affinity DataKd:  300nMAssay Description:HDAC2 containing a C-terminal HIS-Tag (Proteros) and fluorescently-labeled anti-HIS-antibody are diluted in one vial in assay buffer 50 mM Tris, pH 8...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/12/2020
Entry Details
US Patent

TargetHistone deacetylase 2(Human)
Rodin Therapeutics

US Patent
LigandPNGBDBM413938(US10421756, Compound 122)
Affinity DataKd:  300nMAssay Description:HDAC2 containing a C-terminal HIS-Tag (Proteros) and fluorescently-labeled anti-HIS-antibody are diluted in one vial in assay buffer 50 mM Tris, pH 8...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/12/2020
Entry Details
US Patent

TargetHistone deacetylase 2(Human)
Rodin Therapeutics

US Patent
LigandPNGBDBM413935(US10421756, Compound 119)
Affinity DataKd:  300nMAssay Description:HDAC2 containing a C-terminal HIS-Tag (Proteros) and fluorescently-labeled anti-HIS-antibody are diluted in one vial in assay buffer 50 mM Tris, pH 8...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/12/2020
Entry Details
US Patent

TargetHistone deacetylase 1(Human)
Rodin Therapeutics

US Patent
LigandPNGBDBM413935(US10421756, Compound 119)
Affinity DataKd:  300nMAssay Description:HDAC2 containing a C-terminal HIS-Tag (Proteros) and fluorescently-labeled anti-HIS-antibody are diluted in one vial in assay buffer 50 mM Tris, pH 8...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/12/2020
Entry Details
US Patent

TargetHistone deacetylase 2(Human)
Rodin Therapeutics

US Patent
LigandPNGBDBM413936(US10421756, Compound 120)
Affinity DataKd:  300nMAssay Description:HDAC2 containing a C-terminal HIS-Tag (Proteros) and fluorescently-labeled anti-HIS-antibody are diluted in one vial in assay buffer 50 mM Tris, pH 8...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/12/2020
Entry Details
US Patent

TargetHistone deacetylase 2(Human)
Rodin Therapeutics

US Patent
LigandPNGBDBM413934(US10421756, Compound 118)
Affinity DataKd:  300nMAssay Description:HDAC2 containing a C-terminal HIS-Tag (Proteros) and fluorescently-labeled anti-HIS-antibody are diluted in one vial in assay buffer 50 mM Tris, pH 8...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/12/2020
Entry Details
US Patent

TargetHistone deacetylase 2(Human)
Rodin Therapeutics

US Patent
LigandPNGBDBM413945(US10421756, Compound 129)
Affinity DataKd:  300nMAssay Description:HDAC2 containing a C-terminal HIS-Tag (Proteros) and fluorescently-labeled anti-HIS-antibody are diluted in one vial in assay buffer 50 mM Tris, pH 8...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/12/2020
Entry Details
US Patent

TargetHistone deacetylase 2(Human)
Rodin Therapeutics

US Patent
LigandPNGBDBM413946(US10421756, Compound 130)
Affinity DataKd:  300nMAssay Description:HDAC2 containing a C-terminal HIS-Tag (Proteros) and fluorescently-labeled anti-HIS-antibody are diluted in one vial in assay buffer 50 mM Tris, pH 8...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/12/2020
Entry Details
US Patent

TargetHistone deacetylase 2(Human)
Rodin Therapeutics

US Patent
LigandPNGBDBM413943(US10421756, Compound 127)
Affinity DataKd:  300nMAssay Description:HDAC2 containing a C-terminal HIS-Tag (Proteros) and fluorescently-labeled anti-HIS-antibody are diluted in one vial in assay buffer 50 mM Tris, pH 8...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/12/2020
Entry Details
US Patent

TargetHistone deacetylase 2(Human)
Rodin Therapeutics

US Patent
LigandPNGBDBM413944(US10421756, Compound 128)
Affinity DataKd:  300nMAssay Description:HDAC2 containing a C-terminal HIS-Tag (Proteros) and fluorescently-labeled anti-HIS-antibody are diluted in one vial in assay buffer 50 mM Tris, pH 8...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/12/2020
Entry Details
US Patent

TargetHistone deacetylase 1(Human)
Rodin Therapeutics

US Patent
LigandPNGBDBM413940(US10421756, Compound 124)
Affinity DataKd:  300nMAssay Description:HDAC2 containing a C-terminal HIS-Tag (Proteros) and fluorescently-labeled anti-HIS-antibody are diluted in one vial in assay buffer 50 mM Tris, pH 8...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/12/2020
Entry Details
US Patent

TargetHistone deacetylase 2(Human)
Rodin Therapeutics

US Patent
LigandPNGBDBM413941(US10421756, Compound 125)
Affinity DataKd:  300nMAssay Description:HDAC2 containing a C-terminal HIS-Tag (Proteros) and fluorescently-labeled anti-HIS-antibody are diluted in one vial in assay buffer 50 mM Tris, pH 8...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/12/2020
Entry Details
US Patent

TargetHistone deacetylase 2(Human)
Rodin Therapeutics

US Patent
LigandPNGBDBM413942(US10421756, Compound 126)
Affinity DataKd:  300nMAssay Description:HDAC2 containing a C-terminal HIS-Tag (Proteros) and fluorescently-labeled anti-HIS-antibody are diluted in one vial in assay buffer 50 mM Tris, pH 8...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/12/2020
Entry Details
US Patent

TargetHistone deacetylase 2(Human)
Rodin Therapeutics

US Patent
LigandPNGBDBM413939(US10421756, Compound 123)
Affinity DataKd:  300nMAssay Description:HDAC2 containing a C-terminal HIS-Tag (Proteros) and fluorescently-labeled anti-HIS-antibody are diluted in one vial in assay buffer 50 mM Tris, pH 8...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/12/2020
Entry Details
US Patent

Displayed 1 to 50 (of 152 total ) | Next | Last >>
Jump to: